Cardinal Health, Inc. $CAH Shares Sold by New York State Teachers Retirement System

Key Points

• New York State Teachers Retirement System trimmed its stake in Cardinal Health by 3.9% in Q4, selling 8,513 shares and now holding 208,986 shares valued at about $42.95 million; institutional investors own about 87.17% of the company.
• Cardinal Health beat non‑GAAP EPS and raised FY‑2026 guidance to $10.70–$10.80, and added $250M of share repurchases (bringing FY26 buybacks to $1.0B) while reducing debt, but revenue missed estimates and GAAP results were weakened by a $184M goodwill impairment, producing a mixed market reaction.
• Analysts remain broadly positive with a consensus rating of Moderate Buy and an average target of $243.67, while several firms have raised targets (e.g., Jefferies to $270, Morgan Stanley to $255) amid the mixed results.

New York State Teachers Retirement System reduced its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 3.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 208,986 shares of the company's stock after selling 8,513 shares during the period. New York State Teachers Retirement System owned approximately 0.09% of Cardinal Health worth $42,947,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the company. SJS Investment Consulting Inc. boosted its position in Cardinal Health by 1,363.6% in the 3rd quarter. SJS Investment Consulting Inc. now owns 161 shares of the company's stock valued at $25,000 after buying an additional 150 shares during the last quarter. Aventura Private Wealth LLC bought a new position in shares of Cardinal Health during the fourth quarter worth about $25,000. Jones Financial Companies Lllp grew its stake in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock worth $27,000 after purchasing an additional 14,034 shares in the last quarter. JPL Wealth Management LLC bought a new stake in Cardinal Health in the third quarter valued at about $31,000. Finally, Turning Point Benefit Group Inc. bought a new position in Cardinal Health during the 3rd quarter worth approximately $31,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. Morgan Stanley increased their target price on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an "overweight" rating in a report on Tuesday. Robert W. Baird set a $248.00 price objective on shares of Cardinal Health in a report on Friday. JPMorgan Chase & Co. lifted their price objective on shares of Cardinal Health from $209.00 to $243.00 and gave the company a "neutral" rating in a research report on Tuesday, February 10th. William Blair started coverage on Cardinal Health in a report on Tuesday. They set an "outperform" rating on the stock. Finally, Jefferies Financial Group raised their target price on Cardinal Health from $220.00 to $270.00 and gave the company a "buy" rating in a research report on Thursday, January 22nd. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $243.67.

Cardinal Health News Summary

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Q3 non‑GAAP earnings beat estimates and company raised FY‑2026 guidance to $10.70–$10.80, above consensus — the core bullish catalyst. PR Newswire: Q3 Results & Outlook
• Positive Sentiment: Company executed $250M additional share repurchase (bringing FY26 repurchases to $1.0B) and reduced debt — shareholder‑friendly actions that support the share price. PR Newswire: Buybacks & Debt Reduction
• Neutral Sentiment: Wells Fargo cut its price target from $256 to $245 but kept an "overweight" rating, signaling continued analyst confidence despite the trim. Benzinga: Wells Fargo PT Change
• Neutral Sentiment: Full earnings call and transcripts are available for investors who want details on segment performance and management commentary. Yahoo Finance: Earnings Transcript Seeking Alpha: Call Transcript
• Negative Sentiment: Revenue missed expectations ($60.9B reported vs. ~$62.1B est.), which prompted media coverage and short‑term selling pressure despite the EPS beat. Benzinga: Revenue Miss Coverage
• Negative Sentiment: GAAP results were weaker: GAAP operating earnings and GAAP EPS declined, driven in part by a $184M pre‑tax goodwill impairment in the Navista & ION reporting unit — a one‑time charge that reduces headline profitability. PR Newswire: Goodwill Impairment
• Negative Sentiment: Several outlets highlighted the "mixed" nature of the report (EPS/guidance vs. revenue/GAAP weakness), which can increase volatility and keep some investors on the sidelines. CNBC: Mixed Results Coverage

Cardinal Health Price Performance

NYSE CAH opened at $195.13 on Friday. Cardinal Health, Inc. has a 12 month low of $137.75 and a 12 month high of $233.60. The firm has a market capitalization of $45.92 billion, a PE ratio of 28.08, a P/E/G ratio of 1.19 and a beta of 0.53. The company's 50 day simple moving average is $213.73 and its 200 day simple moving average is $205.46.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. During the same quarter in the prior year, the firm posted $2.35 earnings per share. The company's revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Sell-side analysts anticipate that Cardinal Health, Inc. will post 10.79 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st were given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date was Wednesday, April 1st. Cardinal Health's payout ratio is presently 29.35%.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.